From the Cathedral Eye Clinic, Belfast, Northern Ireland, United Kingdom (McNeely, Stewart, Moore); School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Northern Ireland, United Kingdom (Stewart); College of Health and Life Sciences, Aston University, Birmingham, United Kingdom (Moore); Tianjin Medical University, Tianjin, China (Moore).
J Cataract Refract Surg. 2023 Sep 1;49(9):921-928. doi: 10.1097/j.jcrs.0000000000001236.
To assess the 3-month and 12-month postoperative visual performance and subjective quality of vision (QoV) after combined implantation of complementary continuous phase multifocal intraocular lenses (IOLs).
Private practice, United Kingdom.
Case series.
The study enrolled 44 patients undergoing phacoemulsification with implantation of an Artis Symbiose Mid in the dominant eye and an Artis Symbiose Plus in the nondominant eye. Refraction, uncorrected distance visual acuity (UDVA), corrected distance visual acuity, uncorrected intermediate visual acuity (UIVA), uncorrected near visual acuity (UNVA), electronic reading desk, and a QoV questionnaire were evaluated at 3 months and 12 months postoperatively.
The mean binocular UDVA was -0.06 ± 0.08 logMAR and -0.07 ± 0.06 logMAR at 3 months and 12 months ( P = .097), respectively. The mean binocular UIVA was 0.03 ± 0.13 logMAR and 0.03 ± 0.10 logMAR ( P = 1.0), respectively. The mean binocular UNVA was 0.07 ± 0.10 logMAR and 0.07 ± 0.08 logMAR ( P = .875), respectively. There was a significant improvement in QoV for both day and night between 3 and 12 months, with a significant reduction in halos at 12 months. Spectacle independence was reported in 93.2% of cases at 12 months.
The Artis Symbiose Mid and Plus IOL combined implantation provided an excellent range of uncorrected vision at 3 and 12 months. There was a significant improvement in QoV and less halos at 12 months. This IOL combination provided very high rates of complete spectacle independence.
评估联合植入互补连续相位多焦点人工晶状体(IOL)后 3 个月和 12 个月的术后视觉表现和主观视觉质量(QoV)。
英国私人诊所。
病例系列。
该研究纳入了 44 例接受超声乳化白内障吸除术的患者,在优势眼植入 Artis Symbiose Mid,在非优势眼植入 Artis Symbiose Plus。术后 3 个月和 12 个月分别评估屈光度、未矫正远视力(UDVA)、矫正远视力、未矫正中间视力(UIVA)、未矫正近视力(UNVA)、电子阅读台和 QoV 问卷。
双眼平均 UDVA 分别为 -0.06 ± 0.08 logMAR 和 -0.07 ± 0.06 logMAR(P=0.097)。双眼平均 UIVA 分别为 0.03 ± 0.13 logMAR 和 0.03 ± 0.10 logMAR(P=1.0)。双眼平均 UNVA 分别为 0.07 ± 0.10 logMAR 和 0.07 ± 0.08 logMAR(P=0.875)。3 个月至 12 个月期间,QoV 白天和夜间均有显著改善,12 个月时光晕显著减少。12 个月时,93.2%的病例报告无需戴眼镜。
Artis Symbiose Mid 和 Plus IOL 联合植入可在 3 个月和 12 个月时提供出色的未矫正视力。12 个月时 QoV 显著改善,光晕减少。这种 IOL 组合提供了非常高的完全不戴眼镜的比例。